Surgical treatment of atrial fibrillation: integrative review

João Roberto Breda1, Gustavo Calado de Aguiar Ribeiro

  • 1Serviço de Cirurgia Cardíaca, PUC-Campinas, SP, Brasil. jrbreda@hotmail.com.br

Insights

Intraoperative ablation for atrial fibrillation (AF) during heart surgery may improve outcomes. This review synthesizes data supporting the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) consensus on AF ablation effectiveness.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) is a significant risk factor for adverse cardiac events and reduced survival in patients undergoing open heart surgery.
  • Evaluating the success of AF treatment, particularly maintaining normal sinus rhythm, is complex.
  • The International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) developed a consensus statement on intraoperative AF ablation.

Purpose of the Study:

  • To present published data supporting the ISMICS consensus statement on intraoperative AF ablation.
  • To evaluate whether intraoperative AF ablation improves clinical outcomes in patients undergoing cardiac operations.
  • To serve as an update source for the clinical applicability of AF ablation in cardiac surgery.

Main Methods:

  • An integrative review methodology was employed.
  • Synthesis of knowledge from significant studies on intraoperative AF ablation was performed.
  • Data contributing to the ISMICS consensus statement were analyzed.

Main Results:

  • The review synthesizes data relevant to the clinical outcomes of intraoperative AF ablation.
  • Evidence supports the evaluation of AF ablation's role in improving outcomes for cardiac surgery patients.
  • The findings contribute to understanding the success rates of AF reversion and maintenance of sinus rhythm.

Conclusions:

  • Intraoperative AF ablation is a key consideration in patients undergoing cardiac surgery with pre-existing AF.
  • The presented data and ISMICS consensus provide a framework for assessing the benefits of AF ablation.
  • Further understanding of AF ablation's impact on cardiac events and survival is crucial.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD: